Clinical Symptoms and Microbiological Outcomes in Tuberculosis Treatment Trials

Por Bark, C.M., Dietze, R., Okwera, A., Quelapio, M.I., Thiel, B.A., Johnson, J.L.
Publicado em 2011

Inhibition of human immunodeficiency virus-1 (HIV-1) by β-chemokine analogues in mononuclear cells from HIV-1-infected patients with active tuberculosis

Por Toossi, Z, Mayanja-Kizza, H, Baseke, J, Peters, P, Wu, M, Abraha, A, Aung, H, Okwera, A, Hirsch, C, Arts, E
Publicado em 2005

Significant variation in presentation of pulmonary tuberculosis across a high resolution of CD4 strata

Por Chamie, G., Luetkemeyer, A., Walusimbi-Nanteza, M., Okwera, A., Whalen, C. C., Mugerwa, R. D., Havlir, D. V., Charlebois, E. D.
Publicado em 2010

Elevated HIV seroprevalence and risk behavior among Ugandan TB suspects: implications for HIV testing and prevention

Por Srikantiah, P., Lin, R., Walusimbi, M., Okwera, A., Luzze, H., Whalen, C. C., Boom, W. H., Havlir, D. V., Charlebois, E. D.
Publicado em 2007

Comparison of intermittent ethambutol with rifampicin-based regimens in HIV-infected adults with PTB, Kampala

Por Okwera, A., Johnson, J. L., Luzze, H., Nsubuga, P., Kayanja, H., Cohn, D. L., Nunn, P., Ellner, J. J., Whalen, C. C., Mugerwa, R. D.
Publicado em 2006

Time to detection of Mycobacterium tuberculosis as an alternative to quantitative cultures

Por Bark, C. M., Okwera, A., Joloba, M. L., Thiel, B.A., Nakibali, J. G., Debanne, S. M., Boom, W. H., Eisenach, K. D., Johnson, J. L.
Publicado em 2011

T cell activation, apoptosis and cytokine dysregulation in the (co)pathogenesis of HIV and pulmonary tuberculosis (TB)

Por Hertoghe, T, Wajja, A, Ntambi, L, Okwera, A, Aziz, M A, Hirsch, C, Johnson, J, Toossi, Z, Mugerwa, R, Mugyenyi, P, Colebunders, R, Ellner, J, Vanham, G
Publicado em 2000

Efficacy of an unsupervised 8-month rifampicin-containing regimen for the treatment of pulmonary tuberculosis in HIV-infected adults

Por Johnson, J. L., Okwera, A., Nsubuga, P., Nakibali, J. G., Whalen, C. C., Hom, D., Cave, M. D., Yang, Z. H., Mugerwa, R. D., Ellner, J. J.
Publicado em 2000

Sputum Mycobacterium tuberculosis mRNA as a Marker of Bacteriologic Clearance in Response to Antituberculosis Therapy

Por Li, L., Mahan, C. S., Palaci, M., Horter, L., Loeffelholz, L., Johnson, J. L., Dietze, R., Debanne, S. M., Joloba, M. L., Okwera, A., Boom, W. H., Eisenach, K. D.
Publicado em 2010

Mycobacterium africanum Subtype II Is Associated with Two Distinct Genotypes and Is a Major Cause of Human Tuberculosis in Kampala, Uganda

Por Niemann, S., Rüsch-Gerdes, S., Joloba, M. L., Whalen, C. C., Guwatudde, D., Ellner, J. J., Eisenach, K., Fumokong, N., Johnson, J. L., Aisu, T., Mugerwa, R. D., Okwera, A., Schwander, S. K.
Publicado em 2002

The Species Mycobacterium africanum in the Light of New Molecular Markers

Por Niemann, S., Kubica, T., Bange, F. C., Adjei, O., Browne, E. N., Chinbuah, M. A., Diel, R., Gyapong, J., Horstmann, R. D., Joloba, M. L., Meyer, C. G., Mugerwa, R. D., Okwera, A., Osei, I., Owusu-Darbo, E., Schwander, S. K., Rüsch-Gerdes, S.
Publicado em 2004